Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 155

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 8
Chunk 155
---
  
     -  
     41  
     -  
     911,358  
     -  
     -  
     911,358 
  
    Issuance
    of common stock as payment to vendors 
     -  
     -  
     825  
     -  
     3,182,550  
     -  
     -  
     3,182,550 
  
    Elimination
    of deferred underwriting fees 
     -  
     -  
     -  
     -  
     5,690,000  
     -  
     -  
     5,690,000 
  
    Reclassification
    of earnout liability 
     -  
     -  
     -  
     -  
     (4,900,000) 
     -  
     -  
     (4,900,000)
  
    Conversion
    of CERo bridge notes and accrued interest into Series A preferred stock 
     630  
     627,154  
     -  
     -  
     -  
     -  
     -  
     627,154 
  
    Conversion
    of working capital loan into Series A preferred stock 
     1,605  
     1,555,000  
     -  
     -  
     -  
     -  
     -  
     1,555,000 
  
    Issuance
    of Series A shares sold to investors, net 
     7,854  
     6,755,698  
     -  
     -  
     (856,663) 
     -  
     -  
     5,899,035 
  
    Issuance
    of Series A Preferred Warrants 
     -  
     -  
     -  
     -  
     2,000,000  
     (2,000,000) 
     -  
     - 
  
    Issuance
    of common shares to Keystone Capital LLC for equity line of credit 
     -  
     -